NCT05924321View on ClinicalTrials.gov

A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

September 21, 2023

Study Completion Date

September 21, 2023

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Single infusion of Carbetocin

DRUG

Placebo

Single IV infusion of matching placebo

DRUG

Placebo and Moxifloxacin

Single IV infusion of matching placebo in combination with Single Oral dose of Moxifloxacin

Trial Locations (1)

85283

Ferring Investigational Site, Tempe

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY